282 related articles for article (PubMed ID: 23580344)
1. Managing cardiovascular risk in overweight children and adolescents.
Dhuper S; Buddhe S; Patel S
Paediatr Drugs; 2013 Jun; 15(3):181-90. PubMed ID: 23580344
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia in the metabolic syndrome in children.
Gidding SS
J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
[TBL] [Abstract][Full Text] [Related]
3. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
Hoerger TJ; Ahmann AJ
J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
[TBL] [Abstract][Full Text] [Related]
4. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
Basile J; Houston M; Ferrario CM
J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
[No Abstract] [Full Text] [Related]
5. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
Deedwania PC; Maki KC; Dicklin MR; Stone NJ; Ballantyne CM; Davidson MH
J Cardiometab Syndr; 2006; 1(5):295-300. PubMed ID: 17679790
[TBL] [Abstract][Full Text] [Related]
6. Obesity and lipids.
Miller WM; Nori-Janosz KE; Lillystone M; Yanez J; McCullough PA
Curr Cardiol Rep; 2005 Nov; 7(6):465-70. PubMed ID: 16256017
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.
Bray GA; Bellanger T
Endocrine; 2006 Feb; 29(1):109-17. PubMed ID: 16622298
[TBL] [Abstract][Full Text] [Related]
8. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
Robins SJ
Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
[TBL] [Abstract][Full Text] [Related]
9. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
[TBL] [Abstract][Full Text] [Related]
10. Vascular risks and management of obesity in children and adolescents.
Jolliffe CJ; Janssen I
Vasc Health Risk Manag; 2006; 2(2):171-87. PubMed ID: 17319462
[TBL] [Abstract][Full Text] [Related]
11. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
12. Disease risks of childhood obesity in China.
Li YP; Yang XG; Zhai FY; Piao JH; Zhao WH; Zhang J; Ma GS
Biomed Environ Sci; 2005 Dec; 18(6):401-10. PubMed ID: 16544522
[TBL] [Abstract][Full Text] [Related]
13. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia.
Ginsberg HN; Maccallum PR
J Clin Hypertens (Greenwich); 2009 Sep; 11(9):520-7. PubMed ID: 19751468
[TBL] [Abstract][Full Text] [Related]
14. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.
Ginsberg HN; MacCallum PR
J Cardiometab Syndr; 2009; 4(2):113-9. PubMed ID: 19614799
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases.
Ashoor IF; Mansfield SA; O'Shaughnessy MM; Parekh RS; Zee J; Vasylyeva TL; Kogon AJ; Sethna CB; Glenn DA; Chishti AS; Weaver DJ; Helmuth ME; Fernandez HE; Rheault MN;
J Am Heart Assoc; 2019 Jul; 8(14):e012143. PubMed ID: 31286821
[TBL] [Abstract][Full Text] [Related]
16. Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome.
Florentin M; Elisaf MS; Mikhailidis DP; Liberopoulos EN
Curr Pharm Des; 2009; 15(29):3446-62. PubMed ID: 19860690
[TBL] [Abstract][Full Text] [Related]
17. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen mL; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ; ;
Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():S1-113. PubMed ID: 17726407
[No Abstract] [Full Text] [Related]
18. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.
McCrindle BW; Urbina EM; Dennison BA; Jacobson MS; Steinberger J; Rocchini AP; Hayman LL; Daniels SR; ; ;
Circulation; 2007 Apr; 115(14):1948-67. PubMed ID: 17377073
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of exercise therapy to reduce cardiometabolic risk factors in overweight and obese children and adolescents: a systematic review].
Blohm D; Ploch T; Apelt S
Dtsch Med Wochenschr; 2012 Dec; 137(50):2631-6. PubMed ID: 23225186
[TBL] [Abstract][Full Text] [Related]
20. Vascular health in children and adolescents: effects of obesity and diabetes.
Short KR; Blackett PR; Gardner AW; Copeland KC
Vasc Health Risk Manag; 2009; 5():973-90. PubMed ID: 19997578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
